Adjuvant Treatment for POLE Proofreading Domain-Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues

Author(s):: Gool, I.C. van; Rayner, E.; Osse, E.M.; Nout, R.A.; Creutzberg, C.L. (0000-0002-7008-4321); Tomlinson, I.P.M.; Church, D.N.; Smit, V.T.H.B.M. (0000-0003-3730-5652); Wind, N. de (0000-0002-3143-5061); Bosse, T.; Drost, M.

Published: 2018
Publication type: Article / Letter to editor

Date issued: 2018-07-01
Language: English
Is part of: Clinical Cancer Research (2018), Vol. 24, no. 13, p. 3197-3203
hdl: 1887/78832
doi: 10.1158/1078-0432.CCR-18-0266